PDCD1 and neoplasm: For example, the oral administration of Akkermansia in NR-FMT mice preserved the efficacy of anti-PD-1 therapy, with IL-12 promoting the recruitment of CCR9+CXCR3+CD4+T lymphocytes to the tumor bed 264.